Abstract:
The invention relates to a -galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the a-galactoceramide analogs. The methods of manufacture of the invention involve the use of unsaturated intermediate compounds which enable to synthesize a-galactoceramide analogs by a mere metathesis reaction. The a -galactoceramide analogs of the invention are useful as active ingredients of pharmaceutical compositions, particularly in pharmaceutical compositions having anti-cancerous properties.
Abstract:
The invention relates to a -galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the a-galactoceramide analogs. The methods of manufacture of the invention involve the use of unsaturated intermediate compounds which enable to synthesize a-galactoceramide analogs by a mere metathesis reaction. The a -galactoceramide analogs of the invention are useful as active ingredients of pharmaceutical compositions, particularly in pharmaceutical compositions having anti-cancerous properties.
Abstract:
The invention relates to α -galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of manufacture of the invention involve the use of unsaturated intermediate compounds which enable to synthesize α-galactoceramide analogs by a mere metathesis reaction. The α -galactoceramide analogs of the invention are useful as active ingredients of pharmaceutical compositions, particularly in pharmaceutical compositions having anti-cancerous properties.
Abstract:
L'invention concerne de nouveaux dérivés alpha-glycosylcéramide répondant ô la formule générale (S-I), un procédé pour leur préparation ainsi que les compositions pharmaceutiques les comprenant et leurs utilisations.
Abstract:
The invention relates to α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of manufacture of the invention involve the use of unsaturated intermediate compounds which enable to synthesize α-galactoceramide analogs by a mere metathesis reaction. The α-galactoceramide analogs of the invention are useful as active ingredients of pharmaceutical compositions, particularly in pharmaceutical compositions having anti-cancerous properties.
Abstract:
The invention concerns the use of compounds comprising a cyclopentane cycle, substituted in positions (1) and (3) by primary, secondary or tertiary amino groups, identical or different, optionally protected by a protecting group, said amino groups being in cis configuration, for preparing a medicine for treating microbial diseases, such as bacterial infections, viral infections or mycoses.
Abstract:
La présente invention concerne l'utilisation de composés comprenant un cycle cyclopentane, substitué en positions (1) et (3) par des groupements aminés, primaires, secondaires ou tertiaires, identiques ou différents, éventuellement protégés par un groupement protecteur, lesdits groupements aminés étant en configuration cis, pour la préparation d'un médicament destiné au traitement des maladies microbiennes, telle que les infections bactériennes, les viroses ou les mycoses.